Infanrix active ingredients are non-infectious substances from tetanus, diphtheria bacteria, and purified proteins of pertussis bacteria. Each 0.5 mL dose contains: 30 IU (25 Lf U) of diphtheria toxoid.
Infanrix is a vaccine indicated for active immunization against diphtheria, tetanus, and pertussis as a 5-dose series in infants and children 6 weeks to 7 years of age (prior to seventh birthday).
Infanrix is approved for intramuscular administration in infants and children 6 weeks to 7 years of age (prior to the seventh birthday) as a 5-dose series
A primary immunization course of 3 doses administered at 2, 4, and 6 months of age (at intervals of 4 to 8 weeks). The first dose may be given as early as 6 weeks of age
Followed by 2 booster doses, administered at 15 to 20 months of age and at 4 to 6 years of age
Preferred administration site:
Anterolateral aspect of the thigh for most infants younger than 12 months of age
Deltoid muscle of the upper arm for most children 12 months of age to 7 years of age